BANDARAM PHARMA PACKTECH LIMIT Share Price

BANDARAM PHARMA PACKTECH LIMIT Share Price

BSE: 524602
|
Healthcare
|
S Cap
₹ 22.15
+₹0.99 (4.68%)
1D
Last updated 03 Sep, 2026, 09:39 IST

BANDARAM PHARMA PACKTECH LIMIT Share Price Today

As of 3 Sep 2026, BANDARAM PHARMA PACKTECH LIMIT share price is ₹22.15. The stock opened at ₹22.00, compared to its previous close of ₹21.16. During today's trading session, BANDARAM PHARMA PACKTECH LIMIT share price moved in the range of ₹20.50 to ₹22.48, with an average price of ₹21.49 for the day. Looking at its last 52-week, the stock has touched a low of ₹17.25 and a high of ₹49.70.

₹20.50
4.68% up today
₹22.48
1D LOW
1D HIGH

BANDARAM PHARMA PACKTECH LIMIT Returns Calculator

Circuit
L
H
₹16.93
₹25.39
52-week
L
H
₹17.25
₹49.70

About BANDARAM PHARMA PACKTECH LIMIT

BANDARAM PHARMA PACKTECH LIMIT Share Price
ISIN
INE875N01036
Sector Market Cap
₹ 38.03 Cr

Bandaram Pharma Packtech Limited is an India-based holding company. The Company is engaged in trading of paper board and recycled wastepaper. It supplies various categories of recycled paper, both imported and indigenous, to small and medium-sized paper mills, located in the East & West Godavari Districts of Andhra Pradesh. Its recycled paper consists of consumer wastepaper such as old newspapers, notebooks and other textbooks, exercise books, forms and all types of discarded paper. The collection is done by hawkers and dealers who consolidate collections from the small individual shops and supply them to paper manufacturers for pulping. The Company’s subsidiary includes VSR Paper & Packaging Limited.

BANDARAM PHARMA PACKTECH LIMIT Financial Highlights

  • Revenue: BANDARAM PHARMA PACKTECH LIMIT reported revenue of ₹62.94 crore in FY26 vs ₹37.05 crore in FY25. It showed an increase of 69.88% on a yearly basis.
  • Operating Profit: BANDARAM PHARMA PACKTECH LIMIT reported an operating profit of ₹0.44 crore in FY26 vs ₹1.32 crore in FY25. It showed a decrease of 66.67% on a year-on-year basis.
  • Net Profit: BANDARAM PHARMA PACKTECH LIMIT reported a net profit of ₹0.45 crore in FY26 vs ₹0.99 crore in FY25. It showed a decrease of 54.55% on a yearly basis.

BANDARAM PHARMA PACKTECH LIMIT Quarterly Result Highlights

  • BANDARAM PHARMA PACKTECH LIMIT reported revenue of ₹23.95 crore in Jun 2026, compared with ₹26.27 crore in Mar 2026, representing a decrease of 8.83% on a quarter-on-quarter (QoQ) basis.
  • BANDARAM PHARMA PACKTECH LIMIT reported an operating profit of ₹0.92 crore in Jun 2026, compared with ₹0.12 crore in Mar 2026, representing an increase of 666.67% on a quarter-on-quarter (QoQ) basis.
  • BANDARAM PHARMA PACKTECH LIMIT reported a profit of ₹0.68 crore in Jun 2026, compared with ₹0.09 crore in Mar 2026, reflecting an increase of 655.56% on a QoQ basis.
  • The earnings per share (EPS) of BANDARAM PHARMA PACKTECH LIMIT stood at ₹0.83 during Jun 2026.
Know more
Promoters
62.66%
FII
0.00%
Other DII
0.00%
Retail and other
37.33%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Nov 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
38.03
P/E
32.06
P/B
1.42
ROE
1.67%
D/E
0.20
ROCE
3.84%
Div. Yield
0.00%
EPS(TTM)
-0.64
Turnover
0.36
EV/EBITDA
14.73
Net Margin
0.00%
Op. Margin
0.00%
ROA
1.56%
Quick Ratio
0.00
Curr. Ratio
1.65
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Bandaram Pharma outperforming all market indices
Step 2 of 5
Valuation
Expensive
Bandaram Pharma PE is significantly higher than its peers
Step 3 of 5
Earnings
Neutral
Bandaram Pharma earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,25,998.0057.6913.2220.48%0.3217.27%692.920.23%0.66103.81
MANIPAL HEALTH ENTERPRI L93,280.00102.925.6810.59%0.469.51%0.000.00%0.000.00
Max Healthcare96,743.7066.409.0013.42%0.0912.97%91.840.20%0.277.37
Fortis Healthcare68,991.9064.456.9710.53%0.2312.56%122.240.11%0.153.05
Aster DM Healthcare66,430.20183.2014.508.48%0.3110.10%53.530.24%0.435.20
Narayana Hrudayalaya39,297.6048.128.6617.76%0.7611.42%127.100.23%0.7624.77
Global Health39,162.5070.379.8114.05%0.0615.26%149.240.03%0.7318.46
Dr. Lal Path Labs32,118.7058.7912.8020.13%0.0825.56%147.341.08%0.9130.45
KRISHNA INST OF MED SCI L31,878.50162.728.4410.74%0.637.99%93.540.00%0.426.52
Poly Medicure17,789.9057.805.8210.37%0.0812.71%301.170.20%0.4833.15

BANDARAM PHARMA PACKTECH LIMIT Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Revenue₹36.96₹34.08₹18.73
Other Income₹0.09₹0.03₹0.19
Total Revenue₹37.06₹34.11₹18.92
Total Expenses₹35.74₹32.93₹18.60
Profit Before Tax₹1.32₹1.19₹0.33
Tax₹0.32₹0.24₹0.07
Profit After Tax₹0.99₹0.95₹0.26
EPS - Basic₹0.83₹0.79₹0.47
EPS - Diluted₹0.83₹0.79₹0.47

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Profit before tax₹1.32₹1.19₹0.33
Income before WC changes₹2.92₹2.85₹1.34
Change in Assets-₹11.52-₹11.77-₹12.75
Change in Liabilities₹3.99₹5.01₹10.31
Change in WC-₹7.52-₹6.76-₹2.44
Cash flow from Operations-₹4.93-₹4.13-₹1.10
Cash flow from Investing-₹0.08-₹1.58-₹5.30
Cash flow from Financing₹5.09₹5.59₹4.47
Total Cash Flow₹0.08-₹0.11-₹1.93
Cash (Start of the year)₹0.04₹0.16₹2.09
Cash (End of the year)₹0.12₹0.04₹0.16

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023
Non-Current Assets₹8.04₹5.99₹5.11
Current Assets₹30.88₹26.06₹15.06
Total Assets₹38.92₹32.06₹20.17
Current Liabilities₹14.03₹12.24₹7.35
Net Current Asset₹16.85₹13.83₹7.71
Non-Current Liabilities₹9.07₹4.76₹7.69
Equity Capital₹15.82₹15.07₹5.13
Total Equity & Liabilities₹38.92₹32.06₹20.17

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹12.23₹14.84₹10.09₹0.00
Other Income₹0.09₹0.03₹0.00₹0.00
Total Revenue₹12.32₹14.87₹10.09₹0.00
Total Expenses₹12.14₹14.69₹9.82₹0.01
Profit Before Tax₹0.19₹0.17₹0.27-₹0.01
Tax₹0.05₹0.04₹0.07₹0.00
Profit After Tax₹0.14₹0.13₹0.20-₹0.01
EPS - Basic₹0.12₹0.11₹0.68-₹1.44
EPS - Diluted₹0.12₹0.11₹0.68-₹1.44

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹0.19₹0.17₹0.27-₹0.01
Income before WC changes₹0.19₹0.19₹0.27-₹0.01
Change in Assets-₹5.88-₹3.75-₹4.73-₹0.52
Change in Liabilities₹2.49₹0.35₹0.59₹3.45
Change in WC-₹3.39-₹3.40-₹4.14₹2.93
Cash flow from Operations-₹3.25-₹3.26-₹3.87₹2.92
Cash flow from Investing₹0.00-₹1.40-₹2.53-₹1.55
Cash flow from Financing₹3.23₹4.61₹4.40₹0.72
Total Cash Flow-₹0.02-₹0.04-₹2.00₹2.08
Cash (Start of the year)₹0.04₹0.09₹2.08₹0.00
Cash (End of the year)₹0.02₹0.04₹0.09₹2.08

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹6.59₹3.92₹2.53₹0.00
Current Assets₹12.62₹9.43₹5.74₹3.00
Total Assets₹19.21₹13.36₹8.27₹3.00
Current Liabilities₹3.62₹1.14₹0.79₹0.01
Net Current Asset₹9.00₹8.30₹4.95₹2.99
Non-Current Liabilities₹3.49₹0.02₹4.41₹0.00
Equity Capital₹12.10₹12.20₹3.07₹2.99
Total Equity & Liabilities₹19.21₹13.36₹8.27₹3.00
* All values are in INR Crore
Qty
Bid
126
20.61
81
20.6
25
20.51
18
20.5
100
20.49
Ask
Qty
22.34
10
22.35
51
22.4
100
22.42
100
22.43
100
Bid Total: 350
Ask Total: 361
Buy orders: 49%
Sell orders: 51%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
58.99
Neutral
ATR (14)
1.15
Neutral
STOCH(9,6)
89.89
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
43.13
Bearish
UO(9)
49.56
Neutral
ROC(12)
16.78
Bullish
WillR(14)
-10.11
Bearish
Period
Simple value
Exponential vaue
5D
18.96
19.31
10D
18.47
18.88
20D
18.61
19.13
50D
21.48
21.2
100D
24.84
23.4
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
BANDARAM PHARMA PACKTECH LIMIT Share Price
BANDARAM PHARMA PACKTECH LIMIT
Healthcare
Add Stock
Add Another

BANDARAM PHARMA PACKTECH LIMIT Share Price FAQs